CS logo
small CS logo
Associates In Hematology Oncology PC-Upland

Upland, Pennsylvania, United States
Oncologist in Upland, Pennsylvania
1 Medical Center Blvd., Suite 341 Vivacqua Pavilion, Crozer Reg. Cancer Ctr, Upland, PA 19013

About Associates In Hematology Oncology PC-Upland


"Our practice specializes in the diagnosis and treatment of blood diseases (both malignant and benign) and cancer for patients 16 years and older. Our philosophy is that the most important aspect in the management of patients in our specialty involves advances, advocacy, and availability."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
16
Bristol-Myers Squibb
2
SWOG Cancer Research Network
2
Telik
2
Tragara Pharmaceuticals, Inc.
2
GOG Foundation
1
NSABP Foundation Inc
1
Total Rows: 7

Clinical Trials at Associates In Hematology Oncology PC-Upland


During the past decade, Associates In Hematology Oncology PC-Upland conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 16 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
2003-06-01
2006-12-01
Completed
440
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
2004-12-01
2008-07-01
Completed
244
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
2006-07-25
2019-02-11
Completed
57
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501

Rows per page:

1–26 of 26

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Associates In Hematology Oncology PC-Upland" #1 sponsor was "National Cancer Institute (NCI)" with 16 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored, "Telik" with 2 trials sponsored and "Tragara Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Associates In Hematology Oncology PC-Upland" #1 collaborator was "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 9 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 16National CancerInstitute (NCI): 16Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2SWOG Cancer ResearchNetwork: 2SWOG Cancer ResearchNetwork: 2Telik: 2Telik: 2Tragara Pharmaceuticals, Inc.: 2Tragara Pharmaceuticals, Inc.: 2GOG Foundation: 1GOG Foundation: 1NSABP Foundation Inc: 1NSABP Foundation Inc: 1

Created with Highcharts 11.1.0Top CollaboratorsCancer and LeukemiaGroup B: 4Cancer and LeukemiaGroup B: 4NCIC Clinical Trials Group: 4NCIC Clinical Trials Group: 4National Cancer Institute (NCI): 4National Cancer Institute (NCI): 4NRG Oncology: 3NRG Oncology: 3North Central CancerTreatment Group: 3North Central CancerTreatment Group: 3SWOG Cancer ResearchNetwork: 3SWOG Cancer ResearchNetwork: 3Eastern CooperativeOncology Group: 2Eastern CooperativeOncology Group: 2American College ofSurgeons: 1American College ofSurgeons: 1NSABP Foundation Inc: 1NSABP Foundation Inc: 1

Clinical Trials Conditions at Associates In Hematology Oncology PC-Upland


According to Clinical.Site data, the most researched conditions in "Associates In Hematology Oncology PC-Upland" are "Breast Cancer" (3 trials), "Breast Ductal Carcinoma In Situ" (2 trials), "Clear Cell Renal Cell Carcinoma" (2 trials), "HER2/Neu Positive" (2 trials) and "Ovarian Neoplasms" (2 trials). Many other conditions were trialed in "Associates In Hematology Oncology PC-Upland" in a lesser frequency.

Clinical Trials Intervention Types at Associates In Hematology Oncology PC-Upland


Most popular intervention types in "Associates In Hematology Oncology PC-Upland" are "Drug" (25 trials), "Other" (15 trials), "Biological" (14 trials), "Radiation" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Bevacizumab" (8 trials), "Paclitaxel" (6 trials), "Quality-of-Life Assessment" (6 trials) and "Docetaxel" (5 trials). Other intervention names were less common.

Clinical Trials Genders at Associates In Hematology Oncology PC-Upland


The vast majority of trials in "Associates In Hematology Oncology PC-Upland" are 14 trials for "All" genders, 10 trials for "Female" genders and 2 trials for "Male" genders.

Clinical Trials Status at Associates In Hematology Oncology PC-Upland


Currently, there are NaN active trials in "Associates In Hematology Oncology PC-Upland". undefined are not yet recruiting, undefined are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Associates In Hematology Oncology PC-Upland, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Associates In Hematology Oncology PC-Upland, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 23Phase 3: 23Phase 2: 3Phase 2: 3

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 12Active, not recruiting: 12Completed: 11Completed: 11Terminated: 3Terminated: 3